J
Jon Clardy
Researcher at Harvard University
Publications - 990
Citations - 62414
Jon Clardy is an academic researcher from Harvard University. The author has contributed to research in topics: Absolute configuration & Bacteria. The author has an hindex of 116, co-authored 983 publications receiving 56617 citations. Previous affiliations of Jon Clardy include Howard Hughes Medical Institute & University of Chicago.
Papers
More filters
Journal ArticleDOI
Gilmicolin and Mycorrhizinol, Two New Metabolites of Gilmaniella humicolaBARRON
TL;DR: The structure of gilmicolin and mycorrhizinol, two new metabolites isolated from culture filtrates of Gilmaniella humicolaBARRON, have been shown to be 3 and 15 respectively by spectral and chemical studies.
Journal ArticleDOI
Induction of apoptosis in endometrial cancer cells by psammaplysene A involves FOXO1
TL;DR: Increasing nuclear FOXO1 function is important for the induction of apoptosis of endometrial cancer cells by PsA.
Journal ArticleDOI
A new antibacterial octaketide and cytotoxic phenylethanoid glycosides from Pogostemon cablin (Blanco) Benth.
TL;DR: A new octaketide, named cytosporone V (1), and two other known phenylethanoid glycosides (2-3), were isolated from the aerial parts of Pogostemon cablin (Blanco) Benth and showed weak antibacterial activity against two gram-positive bacteria and significant cytotoxicity against four human tumor cell lines.
Journal ArticleDOI
Norsesterterpene peroxides from the sponge Latrunculia sp
TL;DR: The structure of trunculin C methyl ester (3) was determined by X-ray analysis, and the absolute configuration was established by application of the Horeau method as discussed by the authors.
Journal ArticleDOI
Phenolic compounds as antiangiogenic CMG2 inhibitors from costa rican endophytic fungi
Shugeng Cao,Lorna M. Cryan,Kaiane A. Habeshian,Catalina Patricia Morales Murillo,Giselle Tamayo-Castillo,Giselle Tamayo-Castillo,Michael S. Rogers,Jon Clardy +7 more
TL;DR: A high throughput FRET assay was developed for the identification of CMG2 inhibitors as anti-angiogenetic agents and the structure of the two new compounds were elucidated on the basis of extensive spectroscopic analysis, including 1D and 2D NMR experiments.